Feed CLGN
CL

CollPlant Biotechnologies Ltd.

CLGN · NASDAQ

$4.12 +2.74% (+$0.11)
1M +33.77%
Market Cap $5.34M
P/E Ratio -
Div. Yield -
ROE 160.28%
Piotroski F-Score Weak
1/9
Valuation
50 /100
Fair
P/S 13.73x
P/B 1.09x
P/E N/A
Growth
78 /100
Growing
Rev. growth 99.41%
Book val. growth 42.68%
EPS growth N/A
Profitability
0 /100
Weak
Gross margin 319.28%
Net margin 3,376.35%
Op. margin 3,329.05%
Quality
1 /100
Poor
ROIC 171.87%
ROE 160.28%
ROA 143.03%
Debt
60 /100
Moderate
Debt/Equity 0.54x
Current ratio 2.27x
Int. coverage -57.12x
Stability
26 /100
Unstable
Beta 0.74x
Rev. volatility 1,994.91%
EPS volatility 105.23%

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre CLGN
Online

Despre companie

CollPlant Biotechnologies Ltd. (CLGN) is a biotechnology company operating in the field of regenerative medicine. The company focuses on the development and production of biological materials and collagen-based products for the treatment of various health conditions. CollPlant employs advanced technologies in creating bioinks and 3D printing for tissue and organ generation. The company emphasizes innovation and product development that could contribute to improvements in patient care. CollPlant Biotechnologies Ltd. (CLGN) shares could be an intriguing choice for investors interested in the biotechnology sector and regenerative medicine.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Biotechnology

CEO

Yehiel Tal

Employees

39

Headquarters

Rehovot

Evenimente viitoare

02 DEC.

Earnings

Upcoming earnings report

68d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.